Debra M. Prow

670 total citations
13 papers, 265 citations indexed

About

Debra M. Prow is a scholar working on Surgery, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Debra M. Prow has authored 13 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Hematology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Debra M. Prow's work include Testicular diseases and treatments (6 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Debra M. Prow is often cited by papers focused on Testicular diseases and treatments (6 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Debra M. Prow collaborates with scholars based in United States, Spain and South Korea. Debra M. Prow's co-authors include Saroj Vadhan‐Raj, Carl M. Kirsch, Gary W. White, James J. Brokaw, Gary V. Burton, Dawn L. Hershman, Danika L. Lew, Carol M. Moinpour, Anne F. Schott and Charles Kuzma and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Debra M. Prow

13 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debra M. Prow United States	9	103	66	50	47	41	13	265
I Sato Japan	10	46 0.4×	21 0.3×	69 1.4×	25 0.5×	67 1.6×	20	434
Todor Dentchev United States	8	365 3.5×	79 1.2×	47 0.9×	76 1.6×	37 0.9×	13	441
G.W. de Valk-de Roo Netherlands	9	71 0.7×	13 0.2×	42 0.8×	18 0.4×	20 0.5×	11	358
Birgitta Sundell United States	7	35 0.3×	116 1.8×	19 0.4×	32 0.7×	58 1.4×	7	295
G Sciorelli Italy	10	159 1.5×	174 2.6×	16 0.3×	23 0.5×	36 0.9×	29	400
Linda Tsang South Africa	14	29 0.3×	34 0.5×	53 1.1×	25 0.5×	89 2.2×	31	424
John D. Scarlett Australia	11	63 0.6×	73 1.1×	32 0.6×	28 0.6×	28 0.7×	20	264
C Praga Italy	9	112 1.1×	91 1.4×	29 0.6×	45 1.0×	50 1.2×	26	299
M. Bergaglio Italy	12	223 2.2×	19 0.3×	42 0.8×	82 1.7×	16 0.4×	18	396
KB Udupa United States	10	60 0.6×	201 3.0×	15 0.3×	42 0.9×	58 1.4×	21	452

Countries citing papers authored by Debra M. Prow

Since Specialization

Citations

This map shows the geographic impact of Debra M. Prow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra M. Prow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra M. Prow more than expected).

Fields of papers citing papers by Debra M. Prow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra M. Prow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra M. Prow. The network helps show where Debra M. Prow may publish in the future.

Co-authorship network of co-authors of Debra M. Prow

This figure shows the co-authorship network connecting the top 25 collaborators of Debra M. Prow. A scholar is included among the top collaborators of Debra M. Prow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra M. Prow. Debra M. Prow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Henry, N. Lynn, Joseph M. Unger, Anne F. Schott, et al.. (2017). Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. Journal of Clinical Oncology. 36(4). 326–332. 70 indexed citations

Henry, N. Lynn, et al.. (2017). Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202). Cancer Research. 77(4_Supplement). S5–6. 4 indexed citations

Yoon, Han‐Seung, Nathan R. Foster, Preston D. Steen, et al.. (2015). Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). Annals of Oncology. 27(2). 339–344. 37 indexed citations

Fizazi, Karim, Debra M. Prow, Laury Finn, et al.. (2002). Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. British Journal of Cancer. 86(10). 1555–1560. 23 indexed citations

Glaspy, John A., Glen R. Justice, J. Keßler, et al.. (2001). A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. British Journal of Cancer. 84(s1). 17–23. 62 indexed citations

Amato, Robert J. & Debra M. Prow. (2000). Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors. Urologic Oncology Seminars and Original Investigations. 5(4). 134–138. 3 indexed citations

Amato, R. J., et al.. (2000). Radioimmunodetection of residual, recurrent or metastatic germ cell tumors using technetium-99 anti-(α-fetoprotein) Fab′ fragment. Journal of Cancer Research and Clinical Oncology. 126(3). 161–167. 10 indexed citations

Park, Dong Soo, Debra M. Prow, Robert J. Amato, & Christopher J. Logothetis. (1999). Management consideration in nonpulmonary visceral metastatic seminoma of testis. Journal of Korean Medical Science. 14(4). 431–431. 1 indexed citations

Park, Dong Soo, Debra M. Prow, Robert J. Amato, Jae Y. Ro, & Christopher J. Logothetis. (1999). Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic era. Yonsei Medical Journal. 40(2). 137–137. 13 indexed citations

10.

Prow, Debra M. & Saroj Vadhan‐Raj. (1998). Thrombopoietin: biology and potential clinical applications.. PubMed. 12(11). 1597–604, 1607. 13 indexed citations

11.

Prow, Debra M.. (1998). Germ cell tumors: staging, prognosis, and outcome.. PubMed. 16(2). 82–93. 7 indexed citations

12.

Kirsch, Carl M., James J. Brokaw, Debra M. Prow, & Gary W. White. (1992). Mechanism of Platelet Activating Factor-Induced Vascular Leakage in the Rat Trachea. Experimental Lung Research. 18(4). 447–459. 12 indexed citations

13.

Brokaw, James J., Debra M. Prow, Carl M. Kirsch, & Gary W. White. (1991). Effects of platelet-activating factor on vascular permeability and granulocyte recruitment in the rat trachea. Lung. 169(1). 109–119. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact